Microdosing psilocybin ressources
For more scientific studies into psilocybin therapy follow this link.
Microdosing psychedelic drugs associated with increases in conscientiousness and reductions in neuroticism
Journal of Psychedelic Studies, April 2021
First head-to-head trial pits psychedelic therapy against antidepressant
New England Journal of Medicine, April 2021
International study finds 79% of individuals who microdose with psychedelics report improvements in their mental health
Psychopharmacology, October 2020
TAKING PSYCHEDELICS SERIOUSLY
Journal of Palliative Medicine, April 2018
“With an expanding evidence base confirming safety and benefits… it is time to revisit the legitimate therapeutic use of psychedelics.”
POWERFUL SUBSTANCES IN TINY AMOUNTS
An interview study of psychedelic microdosing.
Nordic Studies on Alcohol and Drugs, February 2018
“Respondents generally agreed that proper microdoses did not result in any intoxication. The majority reported some effect that they regarded as positive. The most commonly described effects were health related, with a benign influence noted especially on states of depression and anxiety.”
“Therapeutic effect was also reported for pain management and for a range of conditions including obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), narcolepsy, and migraines.”
PSILOCYBIN FOR DEPRESSION AND ANXIETY IN PATIENTS WITH CANCER
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.
Journal of Psychopharmacology, November 2016
“…psilocybin produced large decreases in clinician- and self-rated measures of depressed mood and anxiety, along with increases in quality of life, life meaning, and optimism, and decreases in death anxiety. At 6-month follow-up, these changes were sustained…”
PSILOCYBIN FOR RAPID AND SUSTAINED REDUCTION IN ANXIETY AND DEPRESSION
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer.
Journal of Psychopharmacology, November 2016
“…psilocybin produced immediate, substantial, and sustained improvements in anxiety and depression and led to decreases in cancer-related demoralization and hopelessness, improved spiritual wellbeing, and increased quality of life.”
PSILOCYBIN WITH PSYCHOLOGICAL SUPPORT FOR TREATMENT-RESISTANT DEPRESSION
The Lancet, May 2016
“Psilocybin was well tolerated by all of the patients, and no serious or unexpected adverse events occurred. Relative to baseline, depressive symptoms were markedly reduced 1 week and 3 months after treatment. Marked and sustained improvements in anxiety and anhedonia were also noted.”
STUDY SHOWS MAGIC MUSHROOMS ARE THE SAFEST DRUG
Popular Science, May 2017
“If you’re looking to play it safe when it comes to illicit substances, look no further than the humble shroom. It’s non-addictive, hard to overdose on, and you can grow it yourself. And, according to a massive report by the Global Drug Survey, it sends the fewest people to the emergency room of any drug on the market.”
POTENTIAL OF PSILOCYBIN TO ALLEVIATE PSYCHOLOGICAL AND SPIRITUAL DISTRESS IN CANCER PATIENTS REVEALED
New York University, January 2013
“Patients who have benefited from psilocybin clinical research have reported less anxiety, improved quality of life, enhanced psychological and spiritual well-being, and a greater acceptance of the life-changes brought on by cancer.”
TheraPsil – Therapeutic Psilocybe for Canadians
“We are a group of seven health professionals who seek to make psilocybin, a psychedelic medicine, legally available to Canadians in need of compassionate treatment for severe psychological distress.”
The Toronto Psychedelic Society
“A community of communities with a multidisciplinary interest in the science, healing, education, and business of psychedelics. Join us for our events around the city.”
Multidisciplinary Association for Psychedelic Studies Canada (MAPS Canada)
“The Multidisciplinary Association for Psychedelic Studies (MAPS) Canada envisions a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.”
Psychedelic Psychotherapy Forum
“Canada’s premiere conference on psychedelic psychotherapy. The Forum engages mental health professionals and all others interested in advancing the ethical and legal use of psychedelic and plant medicines for healing, personal growth and transformation.”
Spirit Plant Medicine Conference
“People are discovering, rediscovering, and developing multiple uses of sacramental entheogenic medicines. The mission of the SPMC is to help guide this work forward by bringing a world-class international group of leading visionary voices to Vancouver.”
The 2020 Psilocybin Service Initiative of Oregon
Campaign for a 2020 ballot initiative to legalize psilocybe therapy in Oregon.
Campaign for 2019 ballot initiative to decriminalize psilocybe mushrooms in Denver.
Here are some links for further reading and research about psilocybe mushrooms and microdosing.